EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Health and well‐being of maturing adults with classic galactosemia

Olivia S Garrett, Jared J Druss, E Naomi Vos, Yu-Ting Debbie Fu, Stephanie Lucia, Patricia E Greenstein, Anna Bauer, Jolanta Sykut-Cegielska, Karolina M Stepien, Cameron Arbuckle, Olga Grafakou, Uta Meyer und 6 weitere

Journal of Inherited Metabolic Disease · 2025

DOI: 10.1002/jimd.12786 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Inherited Metabolic Disease, 2025. Verfasst von Olivia S Garrett und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Human Genetics, Emory University School of Medicine, Atlanta, Georgia, USA. Hauptthemen laut MEDLINE: Galactosemias. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Galactosemia Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Long‐term outcomes in classic galactosemia (CG) have been studied previously, but all prior studies have relied on cohorts of patients that were small in number, or heavily skewed toward children and young adults, or both. Here, we extend what is known about the health and well‐being of maturing adults with CG by analyzing the results of anonymous custom surveys completed by 92 affected individuals, ages 30–78, and 38 unaffected sibling controls, ages 30–79. The median age for patients was 38.5 years and for controls was 41 years. These study participants hailed from 12 different countries predominantly representing Europe and North America. Participants reported on their general life experiences and outcomes in seven different domains including: speech/voice/language, cognition, motor function, cataracts, bone health, psychosocial well‐being, and gastrointestinal health. We also queried women about ovarian function. Our results indicated a prevalence of long‐term complications across all outcome domains that aligned with levels previously reported in younger cohorts. Given the sample size and age range of participants in this study, these findings strongly suggest that the adverse developmental outcomes commonly linked to CG are not progressive with age for most patients. We also tested four candidate modifiers for possible association with each of the outcomes followed, including: days of neonatal milk exposure, rigor of dietary galactose restriction in early childhood, current age, and home continent. We observed no associations that reached even nominal significance, except for the following: cataracts with neonatal milk exposure ( p = 2.347e−04), cataracts with age ( p = 0.018), and bone health with home continent ( p = 0.03).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GalactosemiasHumansFemaleAdultMaleMiddle AgedAgedCase-Control StudiesSurveys and QuestionnairesCataract

Stichwörter der Autor:innen

GALTadultdevelopmental outcomesgalactosemiamodifiers

Autor:innen und Institutionen

  • Department of Human Genetics, Emory University School of Medicine, Atlanta, Georgia, USA.
  • MosaKids Children's Hospital, Department of Pediatrics, Maastricht University Medical Center, Maastricht, Netherlands.
  • Division of Genetics and Genomics, Department of Pediatrics, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Department of Neurology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, USA.
  • Department of Inborn Errors of Metabolism and Pediatrics, Institute of Mother and Child, Warsaw, Poland.
  • Adult Inherited Metabolic Disorders Department, Salford Royal Organization, Northern Care Alliance NHS Foundation Trust, Salford, UK.

ORCID-Profile: Judith L Fridovich-Keil

Förderung

  • Galactosemia Foundation

Zitieren

APA

Garrett, O. S., Druss, J. J., Vos, E. N., Fu, Y. D., Lucia, S., Greenstein, P. E., Bauer, A., Sykut-Cegielska, J., Stepien, K. M., Arbuckle, C., Grafakou, O., Meyer, U., Vanhoutvin, N., Pané, A., Bosch, A. M., Rubio-Gozalbo, E., Berry, G. T., & Fridovich-Keil, J. L. (2025). Health and well‐being of maturing adults with classic galactosemia. Journal of Inherited Metabolic Disease. https://doi.org/10.1002/jimd.12786

Vancouver

Garrett OS, Druss JJ, Vos EN, Fu YD, Lucia S, Greenstein PE, et al. Health and well‐being of maturing adults with classic galactosemia. Journal of Inherited Metabolic Disease. 2025. doi:10.1002/jimd.12786

BibTeX
@article{Garrett2025,
  author = {Garrett, Olivia S and Druss, Jared J and Vos, E Naomi and Fu, Yu-Ting Debbie and Lucia, Stephanie and Greenstein, Patricia E and Bauer, Anna and Sykut-Cegielska, Jolanta and Stepien, Karolina M and Arbuckle, Cameron and Grafakou, Olga and Meyer, Uta and Vanhoutvin, Nele and Pané, Adriana and Bosch, Annet M and Rubio-Gozalbo, Estela and Berry, Gerard T and Fridovich-Keil, Judith L},
  title = {Health and well‐being of maturing adults with classic galactosemia},
  journal = {Journal of Inherited Metabolic Disease},
  year = {2025},
  doi = {10.1002/jimd.12786}
}
Kostenlos starten →